Iceland· IS-EU/1/24/1875/001
Wainzua
A eplontersen product containing eplontersen sodium, registered in Iceland by AstraZeneca AB*. The same ATC class is registered in 13 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Eplontersen is registered in 13 of 19 countries.
Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Eplontersen · ATC N07XX21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Eplontersen sodium
- Manufacturer
- AstraZeneca AB*
- Country
- Iceland (IS)
- ATC code
- N07XX21
- ATC class
- Eplontersen
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eplontersen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumWainzua 45 mgAstraZeneca
- CzechiaWAINZUAAstraZeneca AB, Södertälje
- NorwayWainzuaAstraZeneca AB
- SwedenWainzua 45 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- IrelandWainzua 45 mg solution for injection in pre-filled penAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Wainzua
- Norway · Wainzua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/84d45516-072b-4d96-8962-23391422128a GET /v1/drugs/84d45516-072b-4d96-8962-23391422128a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn í áfylltum lyfjapenna",
"source": "lyfjastofnun",
"atc_raw": "N07XX21",
"marketed": false,
"strength": "45 mg",
"ma_number": "EU/1/24/1875/001",
"substance": "Eplontersen sodium",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í taugasjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45722"
}See everything about eplontersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.